This article moves us up the healthcare value chain by highlighting the impact that COVID-19 has had on clinical trials. Cutter Consortium Senior Consultant Ben van der Schaaf and Pan Xi describe the current state of mHealth along with technology innovations that forward-looking R&D leaders in pharmaceuticals are deploying. Knowing that the current shift will not be temporary, the authors urge healthcare organizations “to adapt and be in the right place at the right time … to prepare for this imminent change.”

Heléne Spjuth examines the economics of mHealth and the resulting challenges and opportunities for all stakeholders in the healthcare ecosystem. In defining the healthcare ecosystem and its various reimbursement models, she shows the “unique circumstances that will serve either as barriers to, or enablers of, mHealth’s efficient implementation.”

Levie Hofstee, cofounder of Neurocast, describes advancements made by his company. Neurocast is a later-stage startup gaining traction in using mHealth to provide real-world data on patients suffering from chronic disease, such as multiple sclerosis, both to aid new discoveries and to support 24/7 data collection during clinical trials.

The COVID-19 pandemic has led to sizable disruptions in international economic activity, impacting all industries, although at different magnitudes. It is now time for decision makers to expand their focus beyond immediate crisis management to actions that will strengthen their competitive play in the medium and long term. Here in Part II of this Advisor series, we take a look at telecom, equipment vendors, and Internet services, in particular.

This week's edition of The Cutter Edge takes a look at why agile adoption fails, why digitization in healthcare is an imperative, how the automotive industry can amplify its competitive advantage, and more!

The COVID-19 pandemic has led to sizable disruptions in international economic activity, impacting all industries, although at different magnitudes. It is now time for decision makers to expand their focus beyond immediate crisis management to actions that will strengthen their competitive play in the medium and long term. In this Advisor series, we take a look at the telecom, media, and technology sectors, in particular, which show relatively strong resilience to the adverse impact of COVID-19. Here in Part I, we begin with the COVID-19 impact to the consumer electronics and media world.

Advances in blockchain technology have been unwavering. Thanks to a slew of current and emerging trends, blockchain is now viewed as a mature and accessible technology and business solution for those seeking to make transactions with greater security, transparency, speed, efficiency, and cost savings. In a Cutter Consortium webinar earlier this year, Karolina Marzantowicz revealed some new blockchain-based innovations — such as the growth of global blockchain consortiums, stablecoins, digital currencies, new service offerings from big tech giants, and decentralized finance platforms — that are revolutionizing the banking and finance industry by transforming both the business and consumer experience in positive ways. In this Advisor, we share six questions asked at the end of the webinar that may help you in your blockchain journey.

Even as digital tools recast the entire healthcare industry model, old problems remain, especially in the centralized and technologically inefficient modes of data management. That’s where good data software testing and quality assurance come into play in the form of test automation. As automation becomes the software development standard for revenue-minded companies, regular testing is required to make sure productivity and security activities are above board.